ARTEM P. GUREEV1, IRINA S. SADOVNIKOVA1, EKATERINA V. CHERNYSHOVA1, EKATERINA P. KRUTSKIKH1, IRINA B. PEVZNER2, LJUBAVA D. ZOROVA2, VERONIKA V. NESTEROVA1, POLINA I. BABENKOVA1, EGOR Y. PLOTNIKOV2,*
BIOCELL, Vol.49, No.5, pp. 873-892, 2025, DOI:10.32604/biocell.2025.063557
- 27 May 2025
Abstract Background: Mitochondrial dysfunction plays a critical role in the pathogenesis of Alzheimer’s disease (AD). Resveratrol is a promising compound for the treatment of various neurodegenerative diseases, including AD. Aims: To investigate mitochondrial damage and the effects of resveratrol on inflammation, cognitive function, and mitochondrial quality control in APP/PS1 mice. Methods: Comparative analysis of mitochondrial DNA (mtDNA) damage was conducted between 10-month-old APP/PS1 mice and age-matched C57BL/6 mice. Assessments included measurement of amyloid-β levels, inflammatory markers, swimming distance in the Morris water maze, and gut microbiome composition. Resveratrol’s effects on cytokine expression, mtDNA levels in plasma, and… More >